# Delivery Order #75N93024F00001

NIH Orders Illumina NextSeq Sequencing Reagents

**Buyer:** National Institutes of Health

**Award Amount:** $29,992.03
**Ceiling:** $29,992.03

**Awarded:** September 03, 2020
**Period of Performance:** Sep 03, 2020 - Feb 29, 2024

**Identifier:** 75N93024F00001
**NAICS:** 334516

The National Institutes of Health (NIH) issued a delivery order under its existing indefinite-delivery, indefinite-quantity (IDIQ) contract with Illumina, Inc., a genomics technology company that supplies sequencing equipment and research consumables. The order covers NextSeq 1000/2000 P2 V3 reagents for 200-cycle sequencing runs—materials used in genetic and biomedical research. Its scope is limited to supplying these compatible reagents; the record provides no additional service or delivery details. Keeping these laboratory consumables available supports ongoing NIH research and sequencing work. The order was placed through the parent IDIQ for Illumina reagents and consumables, which is scheduled to continue through 2025. The available record does not establish whether the parent contract was competitively awarded or sole-source. It identifies no acquisition program, subcontractors, or related previous contracts. The original solicitation reportedly set performance standards for Illumina products, but no solicitation number or further requirements are provided. The order was awarded in 2020, with performance extending into early 2024.

### Description

ILLUMINA NEXTSEQ 1000/2000 P2 REAGENTS (200 CYCLES) V3

[View original record](https://www.usaspending.gov/award/CONT_AWD_75N93024F00001_7529_75N92020D00022_7529)
